First secondary care site goes live
Cambridge University Hospital is the first secondary care site to go live in the DELTA trial, introducing CytospongeTM - TFF3 as a triage...
top of page
News
For the latest project news please see below
- Aug 4, 2020
The tiny sponge that's saving lives
The BBC recently made a short video explaining the Cytosponge test including a short interview with Professor Rebecca Fitzgerald. You can...
- Aug 1, 2020
Cytosponge paper published in The Lancet
A Fitzgerald team paper was published in The Lancet on a study which investigated whether offering the Cytosponge-TFF3 test to patients...
- Jul 3, 2020
UKRI invests £13m in life saving projects
Project DELTA is funded by Innovate UK on behalf of UK Research and Innovation (UKRI). UKRI recently announced that it had invested £13m...
bottom of page